139 related articles for article (PubMed ID: 5049924)
41. [Human amniotic fluid research. In vitro antineoplastic activity].
Gheri Bryk S; Marchesi L; Di Preta F
Arch Ital Anat Embriol; 1981; 86(4):363-84. PubMed ID: 6890333
[No Abstract] [Full Text] [Related]
42. Chemotherapy for solid tumours in adults.
Jamieson GG
Aust N Z J Surg; 1977 Oct; 47(5):694-700. PubMed ID: 273416
[No Abstract] [Full Text] [Related]
43. [Adjuvant chemotherapy for some common malignant tumors].
Wu YF
Zhonghua Yi Xue Za Zhi; 1983 Oct; 63(10):641-4. PubMed ID: 6426727
[No Abstract] [Full Text] [Related]
44. [Clinical trial of 5'-deoxy-5-fluorouridine in malignant tumors under cooperative study (phase II study)].
Murakami M; Ota K; Yasue M; Hoshino A; Kamiya O; Kinoshita T; Yamada M; Hiraiwa K; Hachisuka K; Yamaguchi A
Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1026-35. PubMed ID: 2944975
[No Abstract] [Full Text] [Related]
45. Surgical adjuvant chemotherapy for carcinomas.
Bonadonna G
Antibiot Chemother (1971); 1978; 24():83-94. PubMed ID: 566078
[No Abstract] [Full Text] [Related]
46. Newer concepts in chemotherapy of cancer.
Ansfield FJ; Mackman S; Ramirez G
Oncology; 1972; 26(2):114-20. PubMed ID: 4559039
[No Abstract] [Full Text] [Related]
47. Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
Van Dyk JJ; Clarkson BD; Duschinsky R; Keller O; La Sala E; Krakoff IH
Cancer Res; 1967 Nov; 27(11):2129-36. PubMed ID: 4294532
[No Abstract] [Full Text] [Related]
48. Phase I alternate-day dose study of chromomycin A3.
Reynolds RD; Fisher JI; Jensen PA; Pajak TF; Bateman JR
Cancer Treat Rep; 1976 Sep; 60(9):1251-5. PubMed ID: 1035132
[TBL] [Abstract][Full Text] [Related]
49. Phase 2 study with Baker's Antifol in solid tumors.
Rodriguez V; Richman SP; Benjamin RS; Burgess MA; Murphy WK; Valdivieso M; Banner RL; Gutterman JU; Bodey GP; Freireich EJ
Cancer Res; 1977 Apr; 37(4):980-3. PubMed ID: 139205
[TBL] [Abstract][Full Text] [Related]
50. Results of treatment of malignant tumors with ftorafur.
Blokhina NG; Vozny EK; Garin AM
Cancer; 1972 Aug; 30(2):390-2. PubMed ID: 5051663
[No Abstract] [Full Text] [Related]
51. [Clinical study for augmentation of efficacy of anticancer drugs. 1. Combination therapy by proteolytic enzyme and anticancer drugs].
Kikuchi K; Aneha Y; Natsume R; Kanno H; Kunii Y
Nihon Gan Chiryo Gakkai Shi; 1972 Dec; 7(4):270-8. PubMed ID: 4676339
[No Abstract] [Full Text] [Related]
52. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.
Cameron E; Campbell A
Chem Biol Interact; 1974 Oct; 9(4):285-315. PubMed ID: 4430016
[No Abstract] [Full Text] [Related]
53. Postsurgical adjuvant chemotherapy: a review.
Diekamp U; Lad TE; McGuire WP
Surg Annu; 1981; 13():31-52. PubMed ID: 7025285
[No Abstract] [Full Text] [Related]
54. Anticancer Chinese herbal medicines.
Yeh SD
Am J Chin Med (Gard City N Y); 1973 Jul; 1(2):271-4. PubMed ID: 4359508
[No Abstract] [Full Text] [Related]
55. [Cytostatic chemotherapy in the treatment of malignant tumors].
Langhammer H; Klemm J; Pabst HW
Arztl Forsch; 1966 Aug; 20(8):393-403. PubMed ID: 6014703
[No Abstract] [Full Text] [Related]
56. Chemotherapy in alimentary tract malignomas.
Queisser W; Heim ME
Hepatogastroenterology; 1981 Oct; 28(5):276-83. PubMed ID: 6212524
[No Abstract] [Full Text] [Related]
57. High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs.
Lage H; Aki-Sener E; Yalcin I
Int J Cancer; 2006 Jul; 119(1):213-20. PubMed ID: 16450374
[TBL] [Abstract][Full Text] [Related]
58. Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: a Southeastern Cancer Study Group trial.
Omura GA; Bartolucci AA; Lessner HE; Hill GJ
Cancer Treat Rep; 1984 Jun; 68(6):929-30. PubMed ID: 6547369
[No Abstract] [Full Text] [Related]
59. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
Falkson G; Van der Merwe AM; Falkson HC
Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061
[No Abstract] [Full Text] [Related]
60. Clinical study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in carcinoma of the lung.
Mizgerd JB; Amick RM; Hilal HM; Patno ME
Cancer Chemother Rep; 1971 Feb; 55(1):83-6. PubMed ID: 5121654
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
